Clinical Trials in Boston

Showing 10921-10940 of 15,299 trials

AngioDefender Versus Brachial Artery Ultrasound Imaging

NCT02468336

The objective of this study is to demonstrate that the investigational device, AngioDefender, is comparable to the established procedure referred to as 'brachial artery ultrasound imaging' in their abilities to quantify flow-mediated vasodilation of the brachial artery.

Cardiovascular Diseases

Everist Genomics, Inc171 participantsStarted Aug 2015

Boulder, Colorado, United States • Derby, Connecticut, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

NCT00553462

RATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Erlotinib may make tumor cells more sensitive to radiation therapy. Giving carboplatin and paclitaxel albumin-stabilized nanoparticle formulation together with radiation therapy and erlotinib may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving carboplatin and paclitaxel albumin-stabilized nanoparticle formulation together with radiation therapy and erlotinib works in treating patients with stage III non-small cell lung cancer that cannot be removed by surgery.

Lung Cancer

Alliance for Clinical Trials in Oncology78 participantsStarted Mar 2008

Castro Valley, California, United States • Castro Valley, California, United States • Fremont, California, United States +96 more locations

AngioDefender Versus Brachial Artery Ultrasound Imaging

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Find Trials by Condition in Boston

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

Biopsies of Cancer Patients for Tumor Molecular Characterization

Cardiopulmonary Rehabilitation for Adolescents and Adults With Congenital Heart Disease

Effectiveness of Aurix Therapy in Pressure Ulcers

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

Systems of Support Study for Childhood Depression

Impact of Cerebellar Mass Resection on Pain Processing

NOLAN: Naproxen or Loratadine and Neulasta

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Lesinurad and Febuxostat Combination Extension Study in Gout

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

Unrecognised Obstructive Sleep Apnea Study

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)